Literature DB >> 34125562

Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Racial Differences and a Potential for Reducing Disparities.

Alanna A Morris1, Jeffrey M Testani2, Javed Butler3.   

Abstract

Entities:  

Keywords:  ethnic groups; healthcare disparities; heart failure; race; salt tolerance; sodium-glucose transporter 2 inhibitors

Mesh：

Substances：

Year:  2021        PMID： 34125562      PMCID： PMC8210466          DOI： 10.1161/CIRCULATIONAHA.120.052821

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   39.918


× No keyword cloud information.
  4 in total

Review 1.  Hypertension in Blacks: Individualized Therapy Based on Renin/Aldosterone Phenotyping.

Authors:  J David Spence; Brian L Rayner
Journal:  Hypertension       Date:  2018-06-25       Impact factor: 10.190

2.  Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study.

Authors:  Rozalina G McCoy; Hayley J Dykhoff; Lindsey Sangaralingham; Joseph S Ross; Pinar Karaca-Mandic; Victor M Montori; Nilay D Shah
Journal:  Diabetes Technol Ther       Date:  2019-10-09       Impact factor: 6.118

3.  SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.

Authors:  Faiez Zannad; João Pedro Ferreira; Stuart J Pocock; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Martina Brueckmann; Anne Pernille Ofstad; Egon Pfarr; Waheed Jamal; Milton Packer
Journal:  Lancet       Date:  2020-08-30       Impact factor: 79.321

4.  Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.

Authors:  Matthew Griffin; Veena S Rao; Juan Ivey-Miranda; James Fleming; Devin Mahoney; Christopher Maulion; Nisha Suda; Krishmita Siwakoti; Tariq Ahmad; Daniel Jacoby; Ralph Riello; Lavanya Bellumkonda; Zachary Cox; Sean Collins; Sangchoon Jeon; Jeffrey M Turner; F Perry Wilson; Javed Butler; Silvio E Inzucchi; Jeffrey M Testani
Journal:  Circulation       Date:  2020-05-15       Impact factor: 29.690
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.